|
[Related PubMed/MEDLINE]
Total Number of Papers: 219
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: LOX-1 |
| Long Form |
: lectin-like oxidized LDL receptor-1 |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis. |
BIC, BIE, LDL, PCSK9, SC, SD, VCAM-1 |
| 2 |
2020 |
Electronegative LDL Induces M1 Polarization of Human Macrophages Through a LOX-1-Dependent Pathway. |
LDL, nLDL |
| 3 |
2020 |
Increased APOE glycosylation plays a key role in the atherogenicity of L5 low-density lipoprotein. |
APOE, LDL |
| 4 |
2020 |
Increased Tissue Expression of Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Is Associated with Disease Severity in Chronic Rhinosinusitis with Nasal Polyps. |
CRS, CT, LDL, ROS, SR-B1, SRs |
| 5 |
2020 |
Inflammasome Activation in Human Macrophages Induced by a LDL (-) Mimetic Peptide. |
IL-18, IL-1beta, TLR4 |
| 6 |
2020 |
Interleukin-1beta Promotes Ox-LDL Uptake by Human Glomerular Mesangial Cells via LOX-1. |
Dil-Ox-LDL, HMCs, IL-1beta, oxLDL, PCR |
| 7 |
2020 |
Interleukin-1beta Regulates Lipid Homeostasis in Human Glomerular Mesangial Cells. |
ABCA1, HMCs, IL-1beta, oxLDL |
| 8 |
2020 |
LDL receptors, caveolae and cholesterol in endothelial dysfunction: oxLDLs accomplices or victims? |
Cav-1, oxLDLs |
| 9 |
2020 |
LDL uptake-dependent phosphatidylethanolamine translocation to the cell surface promotes fusion of osteoclast-like cells. |
ABCG1, DKO, LDLR, OCLs, PE, sKO |
| 10 |
2020 |
Natural flavone tricetin suppresses oxidized LDL-induced endothelial inflammation mediated by Egr-1. |
Egr-1, ICAM-1, IL-1beta, MCP-1, oxLDL, ROS, VCAM-1 |
| 11 |
2020 |
Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease. |
CALs, KD, oxLDL, PBMCs |
| 12 |
2020 |
Role of Lectin-like Oxidized LDL Receptor-1 and Syncytiotrophoblast Extracellular Vesicles in the Vascular Reactivity of Mouse Uterine Arteries During Pregnancy. |
AT1, STBEVs |
| 13 |
2020 |
Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 concentrations and prognosis of aneurysmal subarachnoid hemorrhage. |
oxLDL, SAH |
| 14 |
2020 |
Systemic Amelioration via Curcumin in Rats following Splenectomy: Lipid Profile, Endothelial and Oxidative Damage. |
GPx, HDL, LDL, MDA, oxLDL, SC, SCO, SOD, TC, TG, VLDL |
| 15 |
2019 |
Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease. |
alpha-SMA, IL-1beta, NAFLD, oxLDL |
| 16 |
2019 |
Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients. |
HC, LDL, RA |
| 17 |
2019 |
Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis. |
NTFs |
| 18 |
2019 |
Fisetin, via CKIP-1/REGgamma, limits oxidized LDL-induced lipid accumulation and senescence in RAW264.7 macrophage-derived foam cells. |
CKIP-1, FC, OCT1, oxLDL, TC |
| 19 |
2019 |
LOX-1 is involved in TLR2 induced RANKL regulation in peri-implantitis. |
PICF, RANKL, TLR2 |
| 20 |
2019 |
LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression. |
DCFDA, GBM, MDSC, PMN |
| 21 |
2019 |
Paraoxonase 1: The Lectin-Like Oxidized LDL Receptor Type I and Oxidative Stress in the Blood of Men with Type II Obesity. |
CAT, GPx, MDA, PON1, SOD, TNF-alpha |
| 22 |
2019 |
Pathophysiological significance of cylindromatosis in the vascular endothelium and macrophages for the initiation of age-related atherogenesis. |
CYLD, ECs, FABP4, oxLDL, SR-A, SR-BI |
| 23 |
2019 |
The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-kappaB. |
AP-1, DPP-4, ICAM-1, IL-1beta, NF-kappaB, ox-LDL, VCAM-1 |
| 24 |
2019 |
Tofacitinib inhibits ox-LDL-induced adhesion of THP-1 monocytes to endothelial cells. |
HAECs, ICAM-1, IL-1beta, NF-kappaB, oxLDL, ROS, TNF-alpha, VCAM-1 |
| 25 |
2018 |
123I-Labeled oxLDL Is Widely Distributed Throughout the Whole Body in Mice. |
DUR, oxLDL, TACs |
| 26 |
2018 |
ATF4 Involvement in TLR4 and LOX-1-Induced Host Inflammatory Response to Aspergillus fumigatus Keratitis. |
A. fumigatus, ATF4, HCECs, JNK, TLR4 |
| 27 |
2018 |
Endoplasmic reticulum stress induced LOX-1+ CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma. |
ER, HCC, sXBP1 |
| 28 |
2018 |
Fenretinide Inhibits Neutrophil Recruitment and IL-1beta Production in Aspergillus fumigatus Keratitis. |
IL-1beta, JNK, MPO, qRT-PCR |
| 29 |
2018 |
Ginkgolide B ameliorates oxidized low-density lipoprotein-induced endothelial dysfunction via modulating Lectin-like ox-LDL-receptor-1 and NADPH oxidase 4 expression and inflammatory cascades. |
HUVECs, ICAM-1, MCP-1, NOX4, ox, VCAM-1 |
| 30 |
2018 |
Human electronegative LDL induces mitochondrial dysfunction and premature senescence of vascular cells in vivo. |
hTERT, LDL, ROS |
| 31 |
2018 |
Osteopontin is essential for IL-1beta production and apoptosis in peri-implantitis. |
ELISA, IL-1beta, OPN, PICF, rhOPN |
| 32 |
2018 |
Oxidized low-density lipoprotein stimulates epithelial sodium channels in endothelial cells of mouse thoracic aorta. |
ENaC, oxLDL, sGC |
| 33 |
2018 |
Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Expression In Vivo and In Vitro. |
IL, IMQ, oxLDL, TNF |
| 34 |
2018 |
Ulinastatin protects the lungs of COPD rats through the HMGB1/TLR4 signaling pathway. |
COPD, FEV, HMGB1, TLR4, TRAF-6 |
| 35 |
2018 |
Vitamin D3 Induces Gene Expression of Ox-LDL Scavenger Receptors in Streptozotocin-Induced Diabetic Rat Aortas: New Insight into the Role of Vitamin D in Diabetic Atherosclerosis. |
CD36, CD68, oxLDL, RT-PCR, SR-A, STZ |
| 36 |
2017 |
Early Hippocampal i-LTP and LOX-1 Overexpression Induced by Anoxia: A Potential Role in Neurodegeneration in NPC Mouse Model. |
i-LTP, LDL, NPCD, OGD, WT |
| 37 |
2017 |
Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-kappaB and ERK2 activation. |
AMI, ERK, G-CSF, GM-CSF, LDL, NF |
| 38 |
2017 |
Electronegative Low-Density Lipoprotein L5 Impairs Viability and NGF-Induced Neuronal Differentiation of PC12 Cells via LOX-1. |
AD, LDL, NGF |
| 39 |
2017 |
Electronegative Low-Density Lipoprotein L5 Induces Adipose Tissue Inflammation Associated With Metabolic Syndrome. |
LDL, MetS |
| 40 |
2017 |
Elucidation of the Role of Lectin-Like oxLDL Receptor-1 in the Metabolic Responses of Macrophages to Human oxLDL. |
CpG, MAMP, OLR1, TLR9 |
| 41 |
2017 |
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways. |
ACS, LOX-1TG, Oct-1, oxLDL, SIRT1, TF |
| 42 |
2017 |
Expression of LOX-1 in human mesangial cells is increased by Ox-LDL and IL-1beta treatment. |
HMCs, IL-1beta, oxLDL |
| 43 |
2017 |
Hyperoside inhibits the effects induced by oxidized low-density lipoprotein in vascular smooth muscle cells via oxLDL-LOX-1-ERK pathway. |
ERK, oxLDL, VSMCs |
| 44 |
2017 |
LOX-1 is involved in IL-1beta production and extracellular matrix breakdown in dental peri-implantitis. |
ELISA, IL-1beta, MMP2, MMP9, PICF, RT-PCR |
| 45 |
2017 |
Mechanisms of foam cell formation in atherosclerosis. |
LAL, LDL, NCEH, SR, VSMCs |
| 46 |
2017 |
Quercetin Inhibits LPS-Induced Inflammation and ox-LDL-Induced Lipid Deposition. |
AS, COX-2, IL, LPS, MCP-1, MMP-1, oxLDL, QCT, SOCS3 |
| 47 |
2016 |
Collectin CL-P1 utilizes C-reactive protein for complement activation. |
CFH, CL-P1, CRP, SR, TCC |
| 48 |
2016 |
Dihydrotanshinone I Attenuates Atherosclerosis in ApoE-Deficient Mice: Role of NOX4/NF-kappaB Mediated Lectin-Like Oxidized LDL Receptor-1 (LOX-1) of the Endothelium. |
DHT, HUVECs, LPS, NOX4, ROS |
| 49 |
2016 |
Effects of cigarette smoking on cardiovascular-related protein profiles in two community-based cohort studies. |
ESM-1, GDF15, HGF, IL27-A, MMP-1, MMP-10, MMP-12, TRAIL-R2, uPAR |
| 50 |
2016 |
Effects of Porphyromonas gingivalis lipopolysaccharide on the expression of key genes involved in cholesterol metabolism in macrophages. |
ABCG1, ACAT1, LDL, Pg-LPS |
| 51 |
2016 |
Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells. |
ERK, GBE, MMPs, oxLDL, PKC, PPARgamma |
| 52 |
2016 |
High Glucose Enhances oxLDL-Induced Apoptosis in Human Renal Proximal Tubular Epithelial Cells Largely via Inducing Lectin-Like ox-LDL Receptor-1. |
DN, HRPTEpCs, MAPK |
| 53 |
2016 |
Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. |
B-face, CRP, oxLDL |
| 54 |
2016 |
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. |
ER, LDL, PMN-MDSC |
| 55 |
2016 |
Macrophage-mediated cholesterol handling in atherosclerosis. |
ABC, ACAT1, ER, LAL, oxLDL, SR |
| 56 |
2016 |
Membrane-bound heat shock proteins facilitate the uptake of dying cells and cross-presentation of cellular antigen. |
HSPs |
| 57 |
2016 |
Pinoresinol Diglucoside Alleviates oxLDL-Induced Dysfunction in Human Umbilical Vein Endothelial Cells. |
ICAM-1, MDA, NF-kappaB, NO, oxLDL, PCR, PD, ROS, SOD |
| 58 |
2016 |
Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. |
IKK2, LDL, NF-kappaB |
| 59 |
2016 |
Prothrombotic lipoprotein patterns in stroke. |
LDLs |
| 60 |
2016 |
Suppression of EC-SOD by oxLDL During Vascular Smooth Muscle Cell Proliferation. |
EC-SOD, ERK, MEK, oxLDL, ROS, VSMCs |
| 61 |
2016 |
Terminalia bellirica Extract Inhibits Low-Density Lipoprotein Oxidation and Macrophage Inflammatory Response in Vitro. |
DPPH, IL-1beta, LDL, MMP, ROS, TBE, TNF-alpha |
| 62 |
2016 |
The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer. |
CRC |
| 63 |
2015 |
Cross-talk between LOX-1 and PCSK9 in vascular tissues. |
KO, LPS, mtROS, PCSK9, WT |
| 64 |
2015 |
Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1). |
CTS, Nox4, oxLDL, ROS |
| 65 |
2015 |
Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction. |
CKD, LDL, NO |
| 66 |
2015 |
Lectin-like ox-LDL receptor-1 (LOX-1)-Toll-like receptor 4 (TLR4) interaction and autophagy in CATH.a differentiated cells exposed to angiotensin II. |
Ang II, MAPK, oxLDL, siRNA, TLRs, TRIF |
| 67 |
2015 |
Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state. |
LDL, RANKL |
| 68 |
2015 |
Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages. |
oxLDL |
| 69 |
2015 |
LOX-1 in atherosclerotic disease. |
LAB, LDL, LDLC, sLOX-1 |
| 70 |
2015 |
LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. |
oxLDL |
| 71 |
2015 |
Sesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitro. |
EC, HFD, LDL |
| 72 |
2015 |
The association of lectin-like oxidized LDL receptor 1 (LOX-1) K167N and 3'UTR188CT polymorphisms with maternal plasma soluble LOX-1 levels and preeclampsia risk in Turkish population. |
ELISA, PE, sLOX-1, SNPs |
| 73 |
2015 |
The Relationship between Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B and the Cardio-Ankle Vascular Index in Healthy Community Inhabitants: The KOBE Study. |
CAVI, CVD, LAB, LDL, sLOX-1 |
| 74 |
2014 |
Carbamylated low-density lipoprotein induces endothelial dysfunction. |
CKD, cLDL, eNOS, LDL, nLDL, NO, ROS |
| 75 |
2014 |
Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension. |
AML, AT, CRP, DS, EDR, eNOS, MCP-1, SBP |
| 76 |
2014 |
Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. |
HCD, LOX-1TG, oxLDL, WT |
| 77 |
2014 |
Homocysteine induces blood vessel global hypomethylation mediated by LOX-1. |
ECs, Hcy, HHcy, HLP, nMS-PCR, SAH, SAM |
| 78 |
2014 |
Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway. |
ER, oxLDL |
| 79 |
2014 |
OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators. |
ECs, oxLDL |
| 80 |
2014 |
Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis. |
AVS, oxLDL, SR-A1, SR-B1 |
| 81 |
2014 |
Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration. |
CD36, DFO, GCs, oxLDL, RES, TLR4 |
| 82 |
2014 |
Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia. |
NO, PE, ROS |
| 83 |
2014 |
Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. |
eNOS, oxLDL, SAH |
| 84 |
2013 |
ATP-binding cassette transporter A1 expression is decreased in preeclamptic placentas. |
ABCA1, LXRs, oxLDL |
| 85 |
2013 |
Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1. |
oxLDL |
| 86 |
2013 |
Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina. |
ADMA, eNOS, FMD, LAB, NO |
| 87 |
2013 |
Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptor. |
CRP, ECs, HAECs, LDL, LDL-C, ROS |
| 88 |
2013 |
HDL cholesterol in cardiovascular diseases: the good, the bad, and the ugly? |
CAD, CETP, CKD, NO, TLR2 |
| 89 |
2013 |
Human endothelial lecitin-like oxLDL receptor-1 (LOX-1) expression is not associated with impairment of endothelium-dependent vasoreactivity in conduit vessels. |
EDVR, eNOS, FMD, HUVEC, LDL, TNF-alpha |
| 90 |
2013 |
Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia. |
BK, ELISA, LDL, NP, oxLDL, PE, sLOX-1, SNP |
| 91 |
2013 |
Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behcet's disease. |
eNOS, ET-1, NO, oxLDL, SLE |
| 92 |
2013 |
LOX-1: a male hormone-regulated scavenger receptor for atherosclerosis. |
oxLDL |
| 93 |
2013 |
ox-LDL downregulates eNOS activity via LOX-1-mediated endoplasmic reticulum stress. |
BAECs, BFA, eNOS, ER, GRP, oxLDL, PBA, PERK |
| 94 |
2013 |
Oxidized LDL and LOX-1 in experimental sepsis. |
oxLDL |
| 95 |
2013 |
The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis. |
HUVEC, IL-10, JNK, MAPK, oxLDL, SOCS3 |
| 96 |
2013 |
The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity. |
--- |
| 97 |
2012 |
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. |
oxLDL |
| 98 |
2012 |
Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia. |
HO-1, Nrf2, oxLDL |
| 99 |
2012 |
Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells. |
Hep III, HSPG, HUVECs, oxLDL, ROS |
| 100 |
2012 |
Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cells. |
AGEs, mTOR, PI3K, RICTOR |
|
A Search Service for Abbreviation / Long Form
